Wird geladen...
Mirabegron escalation to 50 mg further improves daily urgency and urgency urinary incontinence in Asian patients with overactive bladder
Purpose: To investigate the efficacy and safety of mirabegron dose escalation from 25 to 50 mg in Asian patients with overactive bladder (OAB). Methods: A total of 242 patients (mean age: 67 years) with OAB were randomized to two groups: M25 (mirabegron 25 mg daily for 12 weeks) and M50 (mirabegron...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Elsevier
2019-03-01
|
Schriftenreihe: | Journal of the Formosan Medical Association |
Online Zugang: | http://www.sciencedirect.com/science/article/pii/S0929664618301943 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|